Pancreatitis, Chronic: Clinical Trials

28 trials for Pancreatitis, Chronic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 4 terminated, 2 not yet recruiting, 2 recruiting. 28 Phase 2, 9 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 228Completed 16, Terminated 4, Not yet recruiting 2, Recruiting 2, Withdrawn 2, Active not recruiting 1, Unknown 1
Phase 19Completed 6, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 31Completed 1

Follow Pancreatitis, Chronic: new trials by email Literature Review of Pancreatitis, Chronic trials Research Report on Pancreatitis, Chronic

Trials (filtered) newest first · largest first

All 28 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pirfenidone as Treatment of Chronic Pancreatitis
Pirfenidone 267 mg Oral Tablet, Placebo, PROMIS-Global Health - Chronic Pancreatitis
Phase 2Not yet recruitingVikas Dudeja602026-08-012026-08-10
A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors
Pancreatectomy, Quality-of-Life Assessment, Treatment Planning - Benign Pancreatic Neoplasm, Chronic Pancreatitis
Phase 1 / Phase 2Not yet recruitingOHSU Knight Cancer Institute122026-07-012025-11-25
Soy Tomato Juice to Improve Outcomes in Pancreatitis
Soy-tomato juice product, Will include a soy-tomato juice product to be consumed during the 4 week intervention phase. A total of about 12 ounces (administered in two small cans) of the juice will be consumed - Recurrent Acute Pancreatitis, Chronic Pancreatitis
Phase 1 / Phase 2RecruitingOhio State University352026-04-022026-10-20
Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis
Standard Varenicline Dosing (1 mg BID), Bupropion 150 mg twice daily, Increased Varenicline Dosing (1mg TID) - Pancreatitis, Chronic, Pancreatitis, Acute
Phase 2WithdrawnMayo Clinic2025-11-062026-07-07
Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis/Acute Pancreatitis Associated Diabetes Mellitus
Pioglitazone (PIO), Empagliflozin (EMPA) - Pancreatitis, Chronic, Pancreatitis, Acute
Phase 2RecruitingMayo Clinic502025-05-292026-07-29
Tocilizumab for Painful Chronic Pancreatitis
Tocilizumab 20 MG/ML [Actemra], Sodium Chloride 0.9% Inj - Pancreatitis, Chronic
Phase 2Active not recruitingSoren Schou Olesen322024-05-212026-08-14
Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis
Lidocaine IV - Pancreatic Cancer, Chronic Pancreatitis
Phase 2CompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)302021-01-142023-10-02
Spinal Cord Stimulation for the Treatment of Pain in Chronic Pancreatitis
Spinal Cord Stimulation, Sham - Chronic Pancreatitis, Chronic Pain
Phase 2CompletedAalborg University Hospital162020-11-012024-01-30
Trial of Indomethacin in Chronic Pancreatitis
Indomethacin, Placebo, Endoscopy for Pancreatic Function Testing - Chronic Pancreatitis
Phase 1 / Phase 2CompletedMayo Clinic272020-07-152024-09-04
Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT
Hydroxychloroquine, Placebo - Chronic Pancreatitis, Insulin Dependent Diabetes
Phase 2CompletedThe Cleveland Clinic92017-10-032022-04-08
A Phase IIa Study With Escalating Dose of MS1819-SD
MS1819-SD - Chronic Pancreatitis, Distal Pancreatectomy
Phase 2CompletedAzurRx SAS112017-01-272018-09-28
Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis
Prolastin-C, Placebo - Chronic Pancreatitis
Phase 1 / Phase 2CompletedMedical University of South Carolina482017-01-112023-06-29
Fat Malabsorption in Chronic Pancreatitis
Creon36™ - Chronic Pancreatitis
Phase 2CompletedChildren's Hospital of Philadelphia482016-10-132019-05-03
Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore)
EUS-FNB with ProCore needle, EUS-FNB with SharkCore needle, ProCore needle - Mesenchymal Tumor, Autoimmune Pancreatitis
Phase 2WithdrawnJohns Hopkins University2016-04-012017-05-15
A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
NI-03, Placebo - Chronic Pancreatitis
Phase 1 / Phase 2CompletedKangen Pharmaceuticals, Inc2642016-02-242022-12-16
Carbon Monoxide-Saturated Medium for Islet Isolation
Carbon monoxide-bubbled mediums - Chronic Pancreatitis
Phase 1 / Phase 2CompletedMedical University of South Carolina162015-01-012019-01-04
Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain
Tetrahydrocannabinol, Placebo - Pancreatitis, Chronic, Abdominal Pain
Phase 2CompletedRadboud University Medical Center292012-10-012014-10-28
Pancreatic Perfusion Using Secretin and MRI
Secretin - Chronic Pancreatitis
Phase 1 / Phase 2UnknownUniversity of Nottingham152012-06-012016-02-18
Rituximab in IgG4-RD: A Phase 1-2 Trial
Rituximab - Retroperitoneal Fibrosis, Autoimmune Pancreatitis
Phase 1 / Phase 2CompletedMassachusetts General Hospital302012-04-012017-07-02
Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain
Namisol, Diazepam - Cannabinoid, Tetrahydrocannabinol
Phase 2CompletedRadboud University Medical Center242011-10-012013-07-09

Showing 20 of 28. Sign in to see all of them.

Narrower conditions

Pancreatitis (9)  ·  Abdominal Pain (3)  ·  Exocrine Pancreatic Insufficiency (3)  ·  Autoimmune Pancreatitis (2)  ·  Chronic Pain (2)  ·  Diabetes Mellitus (2)  ·  Diabetes Mellitus, Type 1 (2)  ·  Inflammation (2)  ·  Pain (2)  ·  Behavior, Addictive (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Digestive System Diseases (1)  ·  Insulin Resistance (1)  ·  Lymphadenopathy (1)

Broader conditions

Chronic Disease (28)  ·  Disease Attributes (28)  ·  Pathologic Processes (28)  ·  Pathological Conditions, Signs and Symptoms (28)  ·  Digestive System Diseases (27)  ·  Pancreatic Diseases (27)  ·  Pancreatitis (19)  ·  Immune System Diseases (5)  ·  Neurologic Manifestations (5)  ·  Signs and Symptoms (5)  ·  Autoimmune Diseases (4)  ·  Endocrine System Diseases (4)  ·  Glucose Metabolism Disorders (4)  ·  Metabolic Diseases (4)  ·  Nutritional and Metabolic Diseases (4)

Interventions

Sodium Chloride (3)  ·  Dronabinol (2)  ·  Pioglitazone (2)  ·  Secretin (2)  ·  BID protein, human (1)  ·  Bupropion (1)  ·  Diazepam (1)  ·  Endoscopy (1)  ·  Hydroxychloroquine (1)  ·  Indomethacin (1)  ·  Pancreatectomy (1)  ·  Pancreatic Polypeptide (1)  ·  Pancrelipase (1)  ·  Pregabalin (1)  ·  Rituximab (1)

Sponsors

Mayo Clinic (3)  ·  Aalborg University Hospital (2)  ·  Johns Hopkins University (2)  ·  Medical University of South Carolina (2)  ·  Radboud University Medical Center (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  AzurRx SAS (1)  ·  ChiRhoClin, Inc. (1)  ·  Children's Hospital of Philadelphia (1)  ·  Kangen Pharmaceuticals, Inc (1)  ·  Massachusetts General Hospital (1)  ·  Meridian Bioscience, Inc. (1)  ·  OHSU Knight Cancer Institute (1)  ·  Ohio State University (1)  ·  Pfizer (1)

Countries

United States (15)  ·  Denmark (4)  ·  Netherlands (4)  ·  Russia (2)  ·  Australia (1)  ·  Czechia (1)  ·  France (1)  ·  Hungary (1)  ·  India (1)  ·  Latvia (1)  ·  New Zealand (1)  ·  Poland (1)  ·  Sweden (1)  ·  Ukraine (1)  ·  United Kingdom (1)

Top investigators

Harry van Goor, MD PhD (2)  ·  Hongjun Wang, Ph.D (2)  ·  Arezou Khosroshahi, MD (1)  ·  Babette Zemel, PhD (1)  ·  Betul Hatipoglu, MD (1)  ·  Brett C Sheppard (1)  ·  Dariush Elahi, PhD (1)  ·  Helga A Gulisano, MD (1)  ·  James H Grendell, MD (1)  ·  John H Stone, MD, MPH (1)  ·  John Simpson (1)  ·  Marc G. Besselink, MD PhD MSc (1)  ·  Matthew DiMagno, M.D. (1)

Results publications

PMID 21848870, PMID 22879908, PMID 23548879, PMID 25667206, PMID 27720917, PMID 31412955, PMID 38103842, PMID 38659255, PMID 40622408

NIH funding

2023 (1), R01DK105183 (1), R01DK138871 (1), R21AA017271 (1), R21DK117212 (1)